Press Releases
Jardiance® Demonstrated Cardiovascular (CV) Risk Reduction In People With Type 2 Diabetes At High Risk For CV Events
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial investigating cardiovascular...
Press Releases
Lilly’s Humalog® 200 Units/ML KwikPen® Now Available In U.S. Pharmacies
First and only concentrated mealtime insulin analog may help people with diabetes fit their treatment into their daily lives Humalog® 200 units/mL KwikPen® (insulin lispro...
Press Releases
U.S. Food and Drug Administration Extends Action Date for Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Untreated Advanced Melanoma
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has extended the action date for the supplemental Biologics License Application...
Press Releases
Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the U.S.
Company enters into a collaboration agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute as part...
Press Releases
Bristol-Myers Squibb and The Leukemia & Lymphoma Society Announce Charitable Donation to Support Critical Routine Testing and Awareness for Chronic Myeloid Leukemia Patients
"With the life expectancy of more CML patients increasing, the need for routine PCR testing is very important to ensure optimal treatment results" Bristol-Myers Squibb...
Press Releases
Pall Purchases Exclusive License to Cutting-Edge Acoustic Wave Separation Technology from FloDesign Sonics for Biopharm Application
Pall Corporation, a global leader in filtration, separation and purification, announced the signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology...
Press Releases
Venturing into chemicals in France
Invest in Grenoble-Isère and Rhône Valley - ACHEMA 2015 Hall 9.2, stand D41 Adisseo, Hexcel, Vencorex, Arkema… major international chemical industry stakeholders are investing more...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.